GIM
NVO

Granahan Investment Management’s Novo Nordisk NVO Stock Holding History

Granahan Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,722
Closed -$368K – 217
2017
Q4 		$368K Sell
13,722
-6,870
-33% -$175K 0.03% 194
2017
Q3 		$496K Sell
20,592
-274
-1% -$6.19K 0.04% 172
2017
Q2 		$447K Buy
20,866
+1,292
+7% +$26.1K 0.04% 173
2017
Q1 		$335K Sell
19,574
-854
-4% -$14.9K 0.03% 183
2016
Q4 		$366K Buy
20,428
+3,300
+19% +$59.8K 0.01% 191
2016
Q3 		$356K Buy
+17,128
New +$425K 0.01% 205

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Granahan Investment Management's NVO Position: Q1 2018 in Review

Granahan Investment Management sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 13,722 shares — an estimated $368K sold.

Granahan Investment Management first reported a position in NVO in Q3 2016 and held it in 6 quarters. The position peaked at $496K in Q3 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

  • Granahan Investment Management reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
  • Granahan Investment Management sold 13,722 Novo Nordisk shares in Q1 2018, an estimated $368K.
  • Granahan Investment Management first reported a position in Novo Nordisk in Q3 2016 and held it in 6 quarters.
  • Granahan Investment Management's Novo Nordisk position peaked at $496K in Q3 2017.
  • 553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Granahan Investment Management's 13F filing for Q1 2018, filed 14 May 2018.